Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

ABBV

AbbVie (ABBV)

AbbVie Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:ABBV

<< Previous 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 Next >>

Date	Time	Source	Headline	Symbol	Company
05/11/2022	8:45AM	PR Newswire (US)	Upadacitinib (RINVOQ®) Achieved Clinical Remission and Endoscopic Response at One Year in Phase 3 Maintenance Study in Patients with Crohn's Disease	NYSE:ABBV	AbbVie Inc
05/11/2022	5:45AM	PR Newswire (US)	SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of AbbVie Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 6, 2022 - (NYSE: ABBV)	NYSE:ABBV	AbbVie Inc
05/10/2022	5:07PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
05/09/2022	5:14PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
05/09/2022	5:14PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
05/09/2022	5:14PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
05/09/2022	5:13PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
05/09/2022	5:12PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
05/09/2022	5:12PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
05/09/2022	5:11PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
05/09/2022	5:10PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
05/06/2022	5:45AM	PR Newswire (US)	ABBV SHAREHOLDER ALERT: Jakubowitz Law Reminds AbbVie Shareholders of a Lead Plaintiff Deadline of June 6, 2022	NYSE:ABBV	AbbVie Inc
05/04/2022	5:45AM	PR Newswire (US)	SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of AbbVie Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 6, 2022 - (NYSE: ABBV)	NYSE:ABBV	AbbVie Inc
05/02/2022	9:18AM	TipRanks	BMO Capital Reaffirms Their Buy Rating on AbbVie (ABBV)	NYSE:ABBV	AbbVie Inc
05/02/2022	7:43AM	TipRanks	Why Did AbbVie Stock Fall Despite FDA’s Approval?	NYSE:ABBV	AbbVie Inc
04/29/2022	2:44PM	PR Newswire (US)	RINVOQ® (upadacitinib) Approved by U.S. FDA as an Oral Treatment for Adults with Active Ankylosing Spondylitis	NYSE:ABBV	AbbVie Inc
04/29/2022	10:29AM	Dow Jones News	AbbVie Shares Lower After Revenue Miss	NYSE:ABBV	AbbVie Inc
04/29/2022	7:46AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:ABBV	AbbVie Inc
04/29/2022	7:43AM	PR Newswire (US)	AbbVie Reports First-Quarter 2022 Financial Results	NYSE:ABBV	AbbVie Inc
04/29/2022	5:45AM	PR Newswire (US)	ABBV SHAREHOLDER ALERT: Jakubowitz Law Reminds AbbVie Shareholders of a Lead Plaintiff Deadline of June 6, 2022	NYSE:ABBV	AbbVie Inc
04/28/2022	8:30AM	PR Newswire (US)	Allergan, an AbbVie Company, to Present New Data from its Leading Portfolio of Eye Care Treatments at the 2022 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting	NYSE:ABBV	AbbVie Inc
04/28/2022	8:00AM	PR Newswire (US)	Abbvie and Plexium Enter Into Multi-Target Strategic Collaboration To Develop and Commercialize Targeted Protein Degradation Therapies for Neurological Conditions	NYSE:ABBV	AbbVie Inc
04/27/2022	7:53AM	Dow Jones News	Health Canada Approves AbbVie Treatment for Bipolar Disorder, Schizophrenia	NYSE:ABBV	AbbVie Inc
04/27/2022	7:00AM	PR Newswire (Canada)	Santé Canada approuve VRAYLAR® pour le traitement du trouble bipolaire de type I et de la schizophrénie chez les adultes	NYSE:ABBV	AbbVie Inc
04/27/2022	7:00AM	PR Newswire (Canada)	Health Canada Approves VRAYLAR® (cariprazine) for the Treatment of Bipolar l Disorder and Schizophrenia in Adults	NYSE:ABBV	AbbVie Inc
04/27/2022	5:45AM	PR Newswire (US)	SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of AbbVie Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 6, 2022 - (NYSE: ABBV)	NYSE:ABBV	AbbVie Inc
04/26/2022	10:22AM	TipRanks	AbbVie: What to Expect from Q1 Earnings	NYSE:ABBV	AbbVie Inc
04/26/2022	8:42AM	TipRanks	Berenberg Bank Keeps Their Hold Rating on AbbVie (ABBV)	NYSE:ABBV	AbbVie Inc
04/22/2022	11:28PM	TipRanks	Analysts’ Opinions Are Mixed on These Healthcare Stocks: AbbVie (ABBV) and Quest Diagnostics (DGX)	NYSE:ABBV	AbbVie Inc
04/21/2022	5:14PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:ABBV	AbbVie Inc

Showing the most relevant articles for your search:NYSE:ABBV

<< Previous 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 Next >>

1812 Brewing (PK)

Ethema Health (PK)

Anavex Life Sciences

Northwest Biotherapeutics (QB)

Intergrated Cannabis Sol... (PK)

Digital Brand Media and ... (PK)

Lightwave Logic

Fannie Mae (QB)

Kraig Biocraft Laborator... (QB)

Rennova Health (PK)

Net Savings Link (PK)

RespireRx Pharmaceuticals (PK)

Delayed Upgrade Clock